Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru (Q48718659)
scientific article published in May 1997
Language:
Current Data About Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru
(P31) (Q13442814)
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

(P304) 1421-1427
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

(P407) (Q1860)

(P433) 5
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

(P478) 48
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

(P577) Thursday, May 1, 1997
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

(P921) (Q246068)

(Q11695458)
(P887)

(Q419)
(P887)

(P1433) (Q1161692)
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

(P1476) "Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru" (language: en)
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

(P2093) Garcia HH
(P1545) 1
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

Gilman RH
(P1545) 2
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

Horton J
(P1545) 3
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

Martinez M
(P1545) 4
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

Herrera G
(P1545) 5
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

Altamirano J
(P1545) 6
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

Cuba JM
(P1545) 7
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

Rios-Saavedra N
(P1545) 8
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

Verastegui M
(P1545) 9
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

Boero J
(P1545) 10
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

Gonzalez AE
(P1545) 11
(P248)
(P698) 9153484
(P813) Wednesday, February 14, 2018
(P854) http://europepmc.org/abstract/MED/9153484

other details
description scientific article published in May 1997

External Links
(P356) 10.1212/WNL.48.5.1421
(P698) 9153484